NDC Compounded Drug 26436-5311-1 Tetracaine; Lidocaine Hydrochloride
Gel Topical
Compounded Drug Product Information
Frequently Asked Questions
What is the NDC number assigned to Let Topical Gel?
Let Topical Gel was assigned by its manufacturer with NDC product code 26436-5311. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Let Topical Gel?
The NDC package code 26436-5311-1 was assigned to a 3 mL in 1 SYRINGE of tetracaine; lidocaine hydrochloride administered topical via gel.
Who manufactures this product?
Let Topical Gel is manufactured by an outsourced facility and labeled by Hybrid Pharma. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.